-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on SpyGlass Pharma, Raises Price Target to $45

Benzinga·11/13/2026 21:26:09
Diffusion vocale
Citigroup analyst Yigal Nochomovitz maintains SpyGlass Pharma (NASDAQ:SGP) with a Buy and raises the price target from $42 to $45.